Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba®

CompletedOBSERVATIONAL
Enrollment

6,163

Participants

Timeline

Start Date

November 6, 2013

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
DRUG

insulin degludec

Frequency and timing of visits are based on normal clinical practice for patients with diabetes mellitus requiring insulin therapy.

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01984372 - Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Tresiba® | Biotech Hunter | Biotech Hunter